Suresh B.

Suresh B. has a diverse and extensive work experience in the field of pharmacovigilance and risk management. Suresh is currently serving as the Executive Director and Head of Global Pharmacovigilance at Keros Therapeutics since June 2022. Prior to that, they worked as the Head of PVRM at Collegium Pharmaceutical, Inc. from February 2022 to June 2022.

Suresh also held leadership positions at Constellation Pharmaceuticals, where they served as the Executive Director and Head of Global PV & Risk Management from July 2021 to February 2022, and as the Senior Director and Head of Global PV & Risk Management from June 2019 to July 2021.

Before joining Constellation Pharmaceuticals, Suresh worked as the Director and Global Safety Lead Physician at Amicus Therapeutics from December 2018 to May 2019. Suresh also served as the Clinical Safety Risk Management Lead at CSL Behring from August 2017 to November 2018.

Prior to that, Suresh held various senior roles in safety and risk management at 4C Pharma Solutions, inVentiv Health Clinical, Johnson & Johnson, Pfizer, and Bayer. Suresh'sresponsibilities in these positions included medical assessment, safety evaluation and reporting, and global pharmacovigilance.

Overall, Suresh B. brings a wealth of knowledge and expertise in the field of pharmacovigilance and risk management from their extensive work experience at reputable pharmaceutical companies.

Suresh B. obtained their MBBS degree in General Medicine & Surgery from Andhra Medical College between the years 2000 and 2005. Following that, they pursued a Master of Health Services Administration (MHA) degree in Health Services Administration from Governors State University College of Business from 2007 to 2009.